These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Preparation and analysis of the central nervous system. Jordan WH; Young JK; Hyten MJ; Hall DG Toxicol Pathol; 2011 Jan; 39(1):58-65. PubMed ID: 21139057 [TBL] [Abstract][Full Text] [Related]
25. Perspectives on past practices and future trends in toxicologic neuropathology: notes from a keynote address by Dr. Peter S. Spencer. Bolon B Toxicol Pathol; 2011 Jan; 39(1):15-8. PubMed ID: 21075919 [TBL] [Abstract][Full Text] [Related]
29. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays. Sachana M; Willett C; Pistollato F; Bal-Price A Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625 [TBL] [Abstract][Full Text] [Related]
31. Regulatory Forum Opinion Piece*: Effective Brain Trimming for Regulatory-type Nonclinical Toxicity Studies. Bolon B Toxicol Pathol; 2018 Feb; 46(2):115-120. PubMed ID: 29278994 [TBL] [Abstract][Full Text] [Related]
32. Preparation and analysis of the peripheral nervous system. Jortner BS Toxicol Pathol; 2011 Jan; 39(1):66-72. PubMed ID: 21078921 [TBL] [Abstract][Full Text] [Related]
33. EEG as a cross species indicator of neurotoxicity. Benignus VA Neurobehav Toxicol Teratol; 1984; 6(6):473-83. PubMed ID: 6531053 [TBL] [Abstract][Full Text] [Related]
35. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
36. Determining normal variability in a developmental neurotoxicity test: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Raffaele KC; Fisher JE; Hancock S; Hazelden K; Sobrian SK Neurotoxicol Teratol; 2008; 30(4):288-325. PubMed ID: 18280700 [TBL] [Abstract][Full Text] [Related]
37. Scientific and regulatory issues relevant to assessing risk for developmental neurotoxicity: an overview. Rees DC; Francis EZ; Kimmel CA Neurotoxicol Teratol; 1990; 12(3):175-81. PubMed ID: 2196418 [TBL] [Abstract][Full Text] [Related]
38. The role of histopathology in the identification of immunotoxicity. Haley PJ J Immunotoxicol; 2005 Oct; 2(4):181-3. PubMed ID: 18958671 [TBL] [Abstract][Full Text] [Related]
39. The World weighs in on optimal toxicologic pathology training practices: it's unanimous! Bolon B Toxicol Pathol; 2011 Jan; 39(1):294. PubMed ID: 21378210 [No Abstract] [Full Text] [Related]
40. A modern approach to toxicologic pathology of the nervous system. Eighth international symposium of the Society of Toxicologic Pathologists. Cincinnati, Ohio, May 21-25, 1989. Proceedings. Toxicol Pathol; 1990; 18(1 Pt 2):81-223. PubMed ID: 2367809 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]